NFKB1 and atrial fibrillation: Furthermore, Nakaya et al. demonstrated that the combinatory treatment with 0.05 μM AF and the specific NF‐κB inhibitor SN‐50 potentiates the downregulation of Mcl‐1 and consequently the apoptotic effect.